Immunoglobulin Market Size, Share, Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Immunoglobulin market, 2017-2024(USD Billion)
  • 2.2. Global Immunoglobulin market: Snapshot
•  
• Chapter 3. Immunoglobulin Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Growing incidence of autoimmune diseases
    • 3.2.2. Steep rise in the cases of neurological disorders
  • 3.3. Market Restraints
    • 3.3.1. Strict government guidelines with respect to immunoglobulin products
    • 3.3.2. High side effects risk due to immunoglobulin use
  • 3.4. Opportunities
    • 3.4.1. Technological advancements in purification and production methods
    • 3.4.2. Efforts taken by government and non-government organizations to create awareness regarding autoimmune diseases
  • 3.5. Porter's Five Forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Mode of Delivery
    • 3.6.2. Market attractiveness analysis, by Application
    • 3.6.3. Market attractiveness analysis, by Product Type
•  
• Chapter 4. Global Immunoglobulin Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Immunoglobulin market: company market share, 2017
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Regional Expansion
•  
• Chapter 5. Global Immunoglobulin Market - Mode of Delivery Analysis
  • 5.1. Global Immunoglobulin market: Mode of Delivery overview
    • 5.1.1. Global Immunoglobulin market revenue share, by Mode of Delivery, 2017 and 2024
  • 5.2. Subcutaneous
    • 5.2.1. Global Immunoglobulin market for Subcutaneous, 2017 - 2024(USD Billion)
  • 5.3. Intravenous
    • 5.3.1. Global Immunoglobulin market for Intravenous, 2017 - 2024(USD Billion)
•  
• Chapter 6. Global Immunoglobulin Market - Application Analysis
  • 6.1. Global Immunoglobulin market: Application overview
    • 6.1.1. Global Immunoglobulin market revenue share, by Application, 2017 and 2024
  • 6.2. Hypogammaglobulinemia
    • 6.2.1. Global Immunoglobulin market for Hypogammaglobulinemia, 2017 - 2024 (USD Billion)
  • 6.3. Immunodeficiency Disease
    • 6.3.1. Global Immunoglobulin market for Immunodeficiency Disease, 2017 - 2024 (USD Billion)
  • 6.4. Multifocal Motor Neuropathy
    • 6.4.1. Global Immunoglobulin market for Multifocal Motor Neuropathy, 2017 - 2024 (USD Billion)
  • 6.5. Guillain-Barre Syndrome
    • 6.5.1. Global Immunoglobulin market for Guillain-Barre Syndrome, 2017 - 2024 (USD Billion)
  • 6.6. Myasthenia Gravis
    • 6.6.1. Global Immunoglobulin market for Myasthenia Gravis, 2017 - 2024 (USD Billion)
  • 6.7. Chronic Inflammatory Demyelinating Polyneuropathy
    • 6.7.1. Global Immunoglobulin market for Chronic Inflammatory Demyelinating Polyneuropathy, 2017 - 2024 (USD Billion)
  • 6.8. Idiopathic Thrombocytopenic Purpura
    • 6.8.1. Global Immunoglobulin market for Idiopathic Thrombocytopenic Purpura, 2017 - 2024 (USD Billion)
  • 6.9. Specific Antibody Deficiency
    • 6.9.1. Global Immunoglobulin market for Specific Antibody Deficiency, 2017 - 2024 (USD Billion)
  • 6.10. Inflammatory Myopathies
    • 6.10.1. Global Immunoglobulin market for Inflammatory Myopathies, 2017 - 2024 (USD Billion)
  • 6.11. Others
    • 6.11.1. Global Immunoglobulin market for Others, 2017 - 2024 (USD Billion)
•  
• Chapter 7. Global Immunoglobulin Market - Product Type Analysis
  • 7.1. Global Immunoglobulin market: Application overview
    • 7.1.1. Global Immunoglobulin market revenue share, by Product Type, 2017 and 2024
  • 7.2. IgA
    • 7.2.1. Global Immunoglobulin market for IgA, 2017 - 2024 (USD Billion)
  • 7.3. IgD
    • 7.3.1. Global Immunoglobulin market for IgD, 2017 - 2024 (USD Billion)
  • 7.4. IgG
    • 7.4.1. Global Immunoglobulin market for IgG, 2017 - 2024 (USD Billion)
  • 7.5. IgE
    • 7.5.1. Global Immunoglobulin market for IgE, 2017 - 2024 (USD Billion)
  • 7.6. IgM
    • 7.6.1. Global Immunoglobulin market for IgM, 2017 - 2024 (USD Billion)
•  
• Chapter 8. Global Immunoglobulin Market - Regional Analysis
  • 8.1. Global Immunoglobulin market: Regional overview
    • 8.1.1. Global Immunoglobulin market revenue share, by region, 2017 and 2024
  • 8.2. North America
    • 8.2.1. North America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    • 8.2.2. North America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.2.3. North America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.2.4.2. The U.S. Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.2.4.3. The U.S. Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.2.5. Rest of North America
      • 8.2.5.1. Rest of North America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.2.5.2. Rest of North America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.2.5.3. Rest of North America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    • 8.3.2. Europe Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.3.3. Europe Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.3.4. Germany
      • 8.3.4.1. Germany Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.3.4.2. Germany Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.4.3. Germany Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.3.5. UK
      • 8.3.5.1. UK Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.3.5.2. UK Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.5.3. UK Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.3.6. France
      • 8.3.6.1. France Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.3.6.2. France Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.6.3. France Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.3.7. Rest of Europe
      • 8.3.7.1. Rest of Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.3.7.2. Rest of Europe Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.3.7.3. Rest of Europe Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    • 8.4.2. Asia Pacific Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.4.3. Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.4.4. China
      • 8.4.4.1. China Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.4.4.2. China Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.4.4.3. China Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.4.5. Japan
      • 8.4.5.1. Japan Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.4.5.2. Japan Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.4.5.3. Japan Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.4.6. India
      • 8.4.6.1. India Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.4.6.2. India Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.4.6.3. India Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.4.7. Rest of Asia Pacific
      • 8.4.7.1. Rest of Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.4.7.2. Rest of Asia Pacific Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.4.7.3. Rest of Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    • 8.5.2. Latin America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.5.3. Latin America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.5.4.2. Brazil Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.5.4.3. Brazil Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
      • 8.5.5.2. Rest of Latin America Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
      • 8.5.5.3. Rest of Latin America Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Immunoglobulin market revenue, by Mode of Delivery, 2017 - 2024(USD Billion)
    • 8.6.2. The Middle East and Africa Immunoglobulin market revenue, by Application, 2017 - 2024 (USD Billion)
    • 8.6.3. The Middle East and Africa Immunoglobulin market revenue, by Product Type, 2017 - 2024 (USD Billion)
•  
• Chapter 9. Company Profile
  • 9.1. ADMA Biologics, Inc.
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Therapy portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Shire plc
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Therapy portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. CSL Behring LLC
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Therapy portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Alta Genetics
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Therapy portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. China Biologic Products, Inc.
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Therapy portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Grifols S.A.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Therapy portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. LFB Biomedicaments S.A.
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Therapy portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. Kedrion S.p.A.
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Therapy portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. Sanquin Plasma Products B.V.
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Therapy portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments
  • 9.10. Octapharma AG
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Therapy portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments

Table Of Figures

List of Figures
 
1. Market research process
2. Market research methodology
3. Global Immunoglobulin market revenue, 2017–2024(USD Billion) 
4. Porter’s five forces analysis
5. Immunoglobulin Market attractiveness analysis, by Mode of Delivery
6. Immunoglobulin Market attractiveness analysis, by Application
7. Immunoglobulin Market attractiveness analysis, by Product Type
8. Immunoglobulin: Market attractiveness analysis, by Region
9. Company market share analysis, 2017
10. Global Immunoglobulin market revenue share by Mode of Delivery, 2017 and 2024
11. Global Immunoglobulin market for Subcutaneous, 2017 – 2024(USD Billion)
12. Global Immunoglobulin market for Intravenous, 2017 – 2024 (USD Billion)
13. Global Immunoglobulin market revenue share by Application, 2017 and 2024
14. Global Immunoglobulin market for Hypogammaglobulinemia, 2017 – 2024 (USD Billion)
15. Global Immunoglobulin market for Immunodeficiency Disease, 2017 – 2024 (USD Billion)
16. Global Immunoglobulin market for Multifocal Motor Neuropathy, 2017 – 2024 (USD Billion)
17. Global Immunoglobulin market for Guillain-Barre Syndrome, 2017 – 2024 (USD Billion)
18. Global Immunoglobulin market for Myasthenia Gravis, 2017 – 2024 (USD Billion)
19. Global Immunoglobulin market for Chronic Inflammatory Demyelinating Polyneuropathy, 2017 – 2024 (USD Billion)
20. Global Immunoglobulin market for Idiopathic Thrombocytopenic Purpura, 2017 – 2024 (USD Billion)
21. Global Immunoglobulin market for Specific Antibody Deficiency, 2017 – 2024 (USD Billion)
22. Global Immunoglobulin market for Inflammatory Myopathies, 2017 – 2024 (USD Billion)
23. Global Immunoglobulin market for Others, 2017 – 2024 (USD Billion)
24. North America Immunoglobulin market, 2017 - 2024 (USD Billion)
25. Europe Immunoglobulin market, 2017 - 2024 (USD Billion)
26. Asia Pacific Immunoglobulin market, 2017 - 2024 (USD Billion)
27. Latin America Immunoglobulin market, 2017 - 2024 (USD Billion)
28. The Middle East and Africa Immunoglobulin market, 2017 - 2024 (USD Billion)

Table Of Tables

List of Tables

1. Immunoglobulin market: Market Snapshot                                                                                                                        
2. Drivers of global Immunoglobulin market: Impact analysis
3. Restraints of global Immunoglobulin market: Impact analysis
4. Opportunities of global Immunoglobulin market: Impact analysis
5. North America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
6. North America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
7. North America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
8. North America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
9. North America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
10. The U.S. Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
11. The U.S. Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
12. The U.S. Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
13. The U.S. Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
14. The U.S. Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
15. Rest of North America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
16. Rest of North America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
17. Rest of North America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
18. Rest of North America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
19. Rest of North America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
20. Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024(USD Billion)
21.  Europe Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
22.  Europe Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
23.  Europe Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
24. Europe Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
25. Germany Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
26. Germany Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
27. Germany Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
28. Germany Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
29. Germany Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
30. UK Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
31. UK Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
32. UK Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
33. UK Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
34. UK Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
35. France Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
36. France Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
37. France Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
38. France Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
39. France Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
40. Rest of Europe Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
41. Rest of Europe Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
42. Rest of Europe Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
43. Rest of Europe Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
44. Rest of Europe Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
45. Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
46. Asia Pacific Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
47. Asia Pacific Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
48. Asia Pacific Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
49. Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
50. China Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
51. China Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
52. China Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
53. China Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
54. China Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
55. Japan Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
56. Japan Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
57. Japan Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
58. Japan Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
59. Japan Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
60. India Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
61. India Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
62. India Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
63. India Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
64. India Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
65. Rest of Asia Pacific Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
66. Rest of Asia Pacific Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
67. Rest of Asia Pacific Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
68. Rest of Asia Pacific Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
69. Rest of Asia Pacific Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
70. Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
71. Latin America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
72. Latin America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
73. Latin America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
74. Latin America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
75. Brazil Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
76. Brazil Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
77. Brazil Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
78. Brazil Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
79. Brazil Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
80. Rest of Latin America Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
81. Rest of Latin America Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
82. Rest of Latin America Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
83. Rest of Latin America Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
84. Rest of Latin America Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)
85. The Middle East and Africa Immunoglobulin market revenue, by Mode of Delivery, 2017 – 2024 (USD Billion)
86. The Middle East and Africa Immunoglobulin market revenue, by Subcutaneous, 2017 – 2024 (USD Billion)
87. The Middle East and Africa Immunoglobulin market revenue, by Intravenous, 2017 – 2024 (USD Billion)
88. The Middle East and Africa Immunoglobulin market revenue, by Application, 2017 – 2024 (USD Billion)
89. The Middle East and Africa Immunoglobulin market revenue, by Product Type, 2017 – 2024 (USD Billion)